Kindred Biosciences, Inc. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced total revenue was USD 42.164 million compared to USD 4.256 million a year ago. Operating loss was USD 19.968 million compared to USD 62.567 million a year ago. Net loss was USD 21.796 million compared to USD 61.389 million a year ago. Basic loss per share from continuing operations was USD 0.55 compared to USD 1.59 a year ago.